Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Multiple ACR-Supported Policies Advance at Interim AMA House of Delegates Meeting

From the College  |  November 25, 2024

The ACR and its delegation to the American Medical Association (AMA) House of Delegates (HOD) capped a busy and highly successful interim HOD meeting Nov. 8–12 in Orlando. Hundreds of delegates from medical specialty societies and state medical associations gather at two AMA HOD meetings each year—in June and November—to set the policy and direction for the nation’s largest and most powerful physician organization. The November interim meeting is the smaller of the two and usually includes fewer resolutions.

The ACR’s resolution at this meeting—Medicare payment parity for telemedicine—was supported by several delegations and the Specialty and Service Society (SSS) of the AMA, and it was recommended for reaffirmation. The ACR delegation also worked to shape policy discussions in a number of other areas affecting members. Topics addressed included updates to Medicare Physician Fee Schedule payments, budget cuts and budget neutrality issues, approaches to sustaining community practices, artificial intelligence in healthcare, prior authorization and many more.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

ACR members are encouraged to suggest topics of focus for future ACR resolutions by writing to [email protected]. Many ACR-developed policies and directives have been previously passed by the AMA, addressing issues including copay accumulator policy, third-party pharmacy benefit administrators, stakeholder engagement with Medicare Administrative Contractors, payer financial incentives to switch treatments, selective application of prior authorization, step therapy in Medicare Advantage, biosimilar interchangeability pathways, ensuring an effective H-1B visa program to enhance the rheumatology workforce, drug pricing, drug cost attribution in quality payment programs, pharmacy benefit manager (PBM) reform, opposing the previous Medicare Part B drug payment demonstration and more.

Medicare Payment Parity for Telemedicine

Resolution 227, which addressed Medicare payment parity for telemedicine, was developed by the ACR. Due to the AMA having existing policy that supports the expansion of telemedicine in Medicare, as well as having standing policy that prohibits the AMA from advocating for the valuation of CPT codes, the resolution was recommended for reaffirmation.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The ACR will continue its initiative to develop policy based on the priorities of rheumatologists and coalesce around the support of other concerned stakeholder specialty societies. This advocacy and coalition-building is made possible because ACR members join and maintain memberships in the AMA, allowing the delegation representation at the meeting. Join now to not only access benefits for yourself, but also to support this work to elevate rheumatology issues at the national level.

Therapy Cap Exception Process

The HOD passed Resolution 812, authored by the Michigan Delegation and cosponsored by the ACR, to require all health plans with therapy caps or thresholds to include an exception process that, at a minimum, follows the Medicare standard for therapy cap exceptions.

MIPS Reform

The HOD recommended for reaffirmation Resolution 220, the repeal of the Merit-Based Incentive Payment System (MIPS) and replacement with a practicing physician-designed program that has far less administrative burdens and only adopts measures that have been shown to measurably improve patient outcomes. Although the ACR agrees with the need for MIPS reform, it is working with the AMA and other specialties on long-term reform components for MIPS and the Quality Payment Program, which is a multi-year effort with Congress. The ACR has submitted to the CMS rheumatology-specific measures that have been approved for MIPS adoption.

Other Actions 

The HOD adopted policies from the following ACR-supported resolutions:

  • Resolution 218, which called for the U.S. Department of Labor to establish uniform, time-sensitive provider credentialing standards for third-party administrators serving ERISA plans;
  • Resolution 808, which called for all payers to communicate covered alternatives to patients and providers when a medication is denied;
  • Resolution 818, which called for the banning of retrospective payment denials or recoupments for precertified procedures; and
  • Council on Medical Service Report 4, which called for the elimination of acquisition cost and reimbursement disparities for in-office biosimilar treatment across diverse treatment locations.

The HOD recommended the following ACR-supported resolutions and reports for either reaffirmation or referral for later decision or report back to the HOD:

  • Board of Trustees Report 03, which supports initiatives to expand Stark law waivers to allow independent physicians, in addition to employed or affiliated physicians, to work with hospitals or health entities on quality improvement initiatives to address issues including care coordination and efficiency;
  • Resolution 215, which called for federal and state incentives for recruitment and retention of physicians to practice in rural areas;
  • Resolution 219, which called for permanent telehealth reimbursement from Medicare and all health insurance providers;
  • Resolution 223, which called for mandated economic escalators in insurance contracts;
  • Resolution 605, which called for the AMA to provide $1000 stipends directly to HOD attendees;
  • Resolution 801, which called for reimbursement for managing patient portal messages;
  • Resolution 802, which called for addressing physician burnout with inbox management resources and increased payment; and
  • Resolution 809, which called for all payers to maintain minimum formulary requirements.

Resolutions are introduced and considered by the ACR based on its positions and policies and the work of ACR committees and the Board of Directors. The ACR’s delegation to the AMA House of Delegates consists of Gary Bryant, MD (delegate and delegation chair), Eileen Moynihan, MD (delegate), Cristina Arriens, MD (alternate delegate), Colin Edgerton, MD (alternate delegate), Luke Barre, MD (Young Physician Section representative) and Christina Downey, MD (Young Physician Section representative).

The ACR asks rheumatologists to continue to join or renew membership in the AMA so this work may continue. Rheumatology’s voice at the House of Delegates meeting is determined based on the number of ACR members who are also members of the AMA, so every single person who is a member of both the ACR and the AMA adds to the strength of this effort. Visit the AMA’s membership site to join or renew your AMA membership and receive valuable membership benefits along with helping to advance rheumatology.

Input on the AMA delegation’s work on behalf of the rheumatology community can be directed to [email protected]. If you are experiencing specific issues with payers or have other practice concerns, the ACR offers individualized assistance to members of ACR and ARP. Write to [email protected] with your insurance, coding, billing and other practice issues.

Page: 1 2 3 | Multi-Page
Share: 

Filed under:From the CollegeLegislation & Advocacy Tagged with:ACR advocacyAMA House of Delegates (HOD)House of Delegates interim meeting

Related Articles

    ACR Successfully Leads Coalition in AMA House of Delegates to Support Higher Pediatric Specialist Compensation

    June 25, 2024

    An ACR-led resolution that calls for Medicaid payment parity for pediatric specialists will become AMA policy.

    The ACR’s Representation in American Medical Association Critical as Review Looms

    March 17, 2017

    There is a saying that if the American Medical Association (AMA) did not exist, we would have to invent it. That is just what Dr. Nathan S. Davis did back in 1845 when he called for a national medical convention and laid the foundation for the establishment of the AMA in 1847. This new group would…

    Rheumatology Priorities Advanced at Busy AMA House of Delegates Meeting

    June 16, 2023

    Two ACR-led resolutions on in-office specialty drug dispensing and the proposed NIH Public Access Plan passed the House of Delegates and will become AMA policy.

    Updates from AMA House of Delegates 2023 Interim Meeting

    December 12, 2023

    Last month, the ACR’s delegation to the AMA House of Delegates discussed and advanced resolutions to address specialty workforce shortages, payment reform and access to care.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences